Physician profile
Sonum Singh
NPI 1659765873
$15,907.01
in general payments reported to CMS, 2019-2025
36 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $85.37 · 2021: $392 · 2022: $897 · 2023: $1,232 · 2024: $1,456 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Food and Beverage: $3,384 · Travel and Lodging: $840 · Education: $52.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,098.00 |
| Food and Beverage | $3,384.49 |
| Travel and Lodging | $840.46 |
| Education | $52.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $11,359.70 | 2021-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Novo Nordisk INC | $551.08 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $456.06 | 2021-2024 | Mounjaro, Jardiance, Lyumjev |
| Medtronic, INC. | $357.87 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System, Minimed 770g |
| Amgen INC. | $324.94 | 2021-2025 | Tepezza, Repatha |
| Abbott Laboratories | $303.39 | 2022-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $292.96 | 2021-2024 | |
| Abbvie INC. | $273.62 | 2021-2025 | Synthroid |
| Xeris Pharmaceuticals, INC. | $240.13 | 2021-2024 | Recorlev, Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $190.03 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.68 | 2021-2025 | Jardiance |
| Tandem Diabetes Care, INC. | $173.43 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $157.41 | 2019 | |
| Mannkind Corporation | $152.61 | 2021-2025 | Afrezza |
| Becton, Dickinson and Company | $108.78 | 2021-2022 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonum Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.